Genomic Health Inc (GHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,288 | 2,603 | -1,066 | -1,932 | -9,411 |
| Depreciation Amortization | 7,180 | 5,311 | 3,461 | 1,682 | 6,591 |
| Accounts receivable | -3,183 | -1,188 | -1,189 | -1,866 | -2,316 |
| Accounts payable and accrued liabilities | 2,664 | 1,235 | 1,921 | 630 | -594 |
| Other Working Capital | -199 | -1,798 | -1,795 | -2,323 | -2,545 |
| Other Operating Activity | 10,833 | 7,971 | 4,629 | 3,822 | 13,101 |
| Operating Cash Flow | $21,583 | $14,134 | $5,961 | $13 | $4,826 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,702 | 2,262 | 1,646 | -1,264 | -3,093 |
| PPE Investments | -4,442 | -2,809 | -2,329 | -428 | -3,744 |
| Purchase Of Investment | -500 | 0 | 0 | N/A | N/A |
| Investing Cash Flow | $-2,240 | $-547 | $-683 | $-1,692 | $-6,837 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,983 | 1,129 | 934 | 769 | 1,736 |
| Other Financing Activity | -225 | -182 | -120 | -59 | -1,814 |
| Financing Cash Flow | $2,758 | $947 | $814 | $710 | $-78 |
| Beginning Cash Position | 9,082 | 9,082 | 9,082 | 9,082 | 11,171 |
| End Cash Position | 31,183 | 23,616 | 15,174 | 8,113 | 9,082 |
| Net Cash Flow | $22,101 | $14,534 | $6,092 | $-969 | $-2,089 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,583 | 14,134 | 5,961 | 13 | 4,826 |
| Capital Expenditure | -4,442 | -2,809 | -2,329 | -428 | -3,744 |
| Free Cash Flow | 17,141 | 11,325 | 3,632 | -415 | 1,082 |